STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

CRDF Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 863.3K shares, representing 12% of CARDIFF ONCOLOGY INC in this filing.

FiledJul 27, 2026
Ownership dateJun 30, 2026
Reported shares863.3K
Reported ownership12%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 863.3K
Shared voting power 863.3K
Sole dispositive power 863.3K
Shared dispositive power 863.3K
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$0.84as of Jul 27, 2026
Latest tracked price$0.94as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
BlackRock
CIK
CIK0002012383
Accession
0002012383-26-002222
Form
Schedule 13G/A
Open SEC filing View CRDF ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →